Susan O. Oladeji

FDA investigator

Appears on 15 documents from 2017 to 2024, mostly at sites in Georgia. Most often cites production record review (21 CFR 211.192).

15
Documents on file
5.5
Observations per 483
2017
First seen
2024
Most recent

What they cite most

From 82 observations

Activity by year

2017: 2, 2018: 1, 2019: 2, 2020: 2, 2021: 1, 2022: 4, 2023: 2, 2024: 1

Where

Georgia 9 · North Carolina 2 · Alabama 1 · Florida 1 · Mississippi 1 · Spain 1

Is Susan O. Oladeji coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

15 documents, newest first
FirmOpen
483 Cosco International, Inc.Oct 25, 2024 · Marietta, Georgia
483 Avion Pharmaceuticals, LLCNov 8, 2023 · Alpharetta, Georgia
483 WINDER LABORATORIES, LLCFeb 3, 2023 · WINDER, Georgia
483 GERRESHEIMER PEACHTREE CITY LPDec 12, 2022 · Peachtree City, Georgia
483 Form 483 · FEI 3003121577Sep 9, 2022 · Martorelles, Spain
483 Havix Group Inc d/b/a Aavis PharmaceuticalsApr 19, 2022 · Hoschton, Georgia
483 Olympia Compounding PharmacyMar 2, 2022 · Orlando, Florida

About this profile

What does Susan O. Oladeji inspect?

Susan O. Oladeji appears on 15 documents on file covering 13 sites, mostly in Georgia.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.160 and 21 CFR 211.84.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Susan O. Oladeji is dated Oct 25, 2024.